After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Axonics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Axonics Inc is $3.51B. A total of 0.73 million shares were traded on the day, compared to an average of 1.27M shares.
In the most recent transaction, COHEN RAYMOND W sold 35,161 shares of AXNX for 67.74 per share on Jan 31 ’24. After the transaction, the Chief Executive Officer now owns 188,835 company shares. In a previous transaction on Jan 31 ’24, Ford Alfred J Jr sold 16,615 shares at 67.74 per share. AXNX shares that Chief Commercial Officer owns now total 43,450.
Among the insiders who sold shares, Woock John disposed of 15,899 shares on Jan 31 ’24 at a per-share price of $67.74. This resulted in the EVP, Chief Mktg/Strtgy Officer holding 77,403 shares of AXNX after the transaction. In another insider transaction, Noblett Karen sold 11,288 shares at $67.74 per share on Jan 31 ’24. Company shares held by the Chief Medical Officer now total 34,428.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, AXNX has a high of $69.68 and a low of $47.59.
As of this writing, AXNX has an earnings estimate of -$0.1 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.06 per share and a lower estimate of -$0.14. The company reported an EPS of $0.08 in the last quarter, which was 260.00% higher than expectations of -$0.05.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AXNX’s latest balance sheet shows that the firm has $220.88M in Cash & Short Term Investments as of fiscal 2021. There were $10.42M in debt and $26.87M in liabilities at the time. Its Book Value Per Share was $12.56, while its Total Shareholder’s Equity was $482.44M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AXNX is Buy with a score of 3.54.
